ANI PHARMACEUTICALS INC (ANIP)
$72.83-$0.68 (-0.93%) Today
Stephen P. Carey - OfficerStephen P. Carey - OfficerStephen P. Carey - OfficerANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
https://www.anipharmaceuticals.comSEC filings for ANIP on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 24,387 | $1.95M |
| Grant or award | 6 | 28,447 | |
| Option exercise | 4 | 13,250 | |
| Tax withholding / forfeiture | 1 | 2,466 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
108 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Henry O. Gosebruch - Director | Grant or award | Common Stock | 6,662 | $0.00 | - | |
| Nikhil Lalwani - Officer | Open-market sale | Common Stock | 5,400 | $74.30 | $401K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $75.48 | $38K | |
| Ori Gutwerg - Officer | Open-market sale | Common Stock | 3,162 | $77.00 | $243K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $81.36 | $232K | |
| Meredith Cook - Officer | Tax withholding / forfeiture | Common Stock | 2,466 | $79.20 | $195K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $81.84 | $41K | |
| Stephen P. Carey - Officer | Option exercise | Common Stock | 3,313 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 3,313 | $86.00 | $285K | |
| Stephen P. Carey - Officer | Option exercise | Stock Option (right to buy) | 3,313 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $84.12 | $240K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $82.03 | $41K | |
 Jeanne Thoma - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Renee P. Tannenbaum - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Antonio R. Pera - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Matthew J. Leonard - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Thomas Haughey - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Thomas Haughey - Director | Open-market sale | Common Stock | 2,000 | $80.88 | $162K | |
| Stephen P. Carey - Officer | Option exercise | Common Stock | 3,312 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 3,312 | $80.00 | $265K | |
| Stephen P. Carey - Officer | Option exercise | Stock Option (right to buy) | 3,312 | $49.51 | $164K | |
 Patrick D. Walsh - Director | Open-market sale | Common Stock | 3,973 | $80.75 | $321K | |
| Patrick D. Walsh - Director | Open-market sale | Common Stock | 10,000 | $80.63 | $806K | |
| Thomas Andrew Rowland - Officer | Open-market sale | Common Stock | 459 | $79.21 | $36K | |
| Nikhil Lalwani - Officer | Open-market sale | Common Stock | 55,000 | $77.57 | $4.27M | |
| Ori Gutwerg - Officer | Open-market sale | Common Stock | 2,772 | $79.50 | $220K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $78.16 | $39K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $77.95 | $39K | |
| Thomas Andrew Rowland - Officer | Open-market sale | Common Stock | 4,772 | $74.91 | $357K | |
| Christopher Mutz - Officer | Open-market sale | Common Stock | 3,162 | $71.64 | $227K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $72.62 | $36K | |
| Christopher Mutz - Officer | Open-market sale | Common Stock | 2,121 | $74.22 | $157K | |
| Christopher Mutz - Officer | Tax withholding / forfeiture | Common Stock | 3,314 | $74.04 | $245K | |
| Christopher Mutz - Officer | Open-market sale | Common Stock | 3,602 | $74.18 | $267K | |
| Nikhil Lalwani - Officer | Tax withholding / forfeiture | Common Stock | 17,060 | $74.04 | $1.26M | |
| Ori Gutwerg - Officer | Tax withholding / forfeiture | Common Stock | 3,314 | $74.04 | $245K | |
| Krista Davis - Officer | Open-market sale | Common Stock | 5,087 | $74.13 | $377K | |
| Krista Davis - Officer | Open-market sale | Common Stock | 1,485 | $75.00 | $111K | |
| Stephen P. Carey - Officer | Tax withholding / forfeiture | Common Stock | 5,150 | $74.04 | $381K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| NIKHIL LALWANI | Director, Officer | 5,400 | $401K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
ANI PHARMACEUTICALS INC (ANIP) had 16 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for ANIP runs to 108 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ANIP were filed in the last 90 days.
10 insider sales of ANIP were filed in the last 90 days, totaling $1.95M.
This page tracks ANIP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ANIP to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
